News & Updates
Filter by Specialty:
Brolucizumab for neovascular age-related macular degeneration holds up in real world
The use of brolucizumab for the treatment of patients with neovascular age-related macular degeneration (nAMD) in the real-world setting appears to be effective and safe, consistent with data from pivotal trials, as reported in a study.
Brolucizumab for neovascular age-related macular degeneration holds up in real world
30 Sep 2022
SGLT2 inhibitors potentially protective against dry eye disease
Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.
SGLT2 inhibitors potentially protective against dry eye disease
29 Sep 2022
New ROTA imaging technique improves early diagnosis of glaucoma
Researchers from the University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK) have jointly developed an advanced imaging technique for retinal nerve fibre layer optical texture analysis (ROTA) that can improve the detection of early optic nerve damage in glaucoma.
New ROTA imaging technique improves early diagnosis of glaucoma
29 Sep 2022
Vision impairment tied to depression, anxiety in children
Children with vision impairment are at higher risk of developing symptoms of depression and anxiety, according to a study, noting that surgical treatment of strabismus may improve these symptoms.